Glibenclamide

What is Glibenclamide?

Glibenclamide is an oral antidiabetic medication that belongs to the sulfonylurea class of drugs. It is primarily used to treat type 2 diabetes mellitus by helping to lower blood glucose levels. This medication is effective only in patients who still have some functioning pancreatic beta cells that can produce insulin.

Uses

Glibenclamide has several documented medical uses:

• Type 2 diabetes mellitus: The primary use is as a second-line treatment for type 2 diabetes when diet and exercise alone are insufficient to control blood sugar levels.
• Combination therapy: Often used alongside other antidiabetic medications such as metformin to achieve better glucose control.
• Gestational diabetes: In some countries, it may be prescribed for gestational diabetes when insulin therapy is not preferred or available.
• Neonatal diabetes: Used in certain forms of neonatal diabetes caused by specific genetic mutations affecting potassium channels.
• Bridge therapy: Sometimes employed as a temporary measure while transitioning patients between different diabetes treatment regimens.

How it works

Glibenclamide works by binding to specific receptors on pancreatic beta cells called sulfonylurea receptors, which are part of ATP-sensitive potassium channels. This binding causes these channels to close, leading to depolarization of the cell membrane and subsequent opening of calcium channels. The influx of calcium triggers the release of insulin from the beta cells, thereby lowering blood glucose levels.

Side effects

Common side effects include:

Submit Your Paper

• Hypoglycemia (low blood sugar)
• Weight gain
• Nausea and stomach upset
• Diarrhea or constipation
• Dizziness
• Headache
• Skin rash or itching
• Increased appetite

Serious side effects to watch for:

• Severe hypoglycemia with confusion, seizures, or loss of consciousness
• Severe allergic reactions including difficulty breathing or swelling
• Blood disorders such as low white blood cell or platelet counts
• Liver problems indicated by yellowing of skin or eyes
• Severe skin reactions including Stevens-Johnson syndrome

Warnings and precautions

• Kidney and liver impairment: Patients with severe kidney or liver disease should avoid glibenclamide as it may accumulate and cause prolonged hypoglycemia.
• Elderly patients: Older adults are at higher risk for hypoglycemia and should be monitored closely, often requiring lower doses.
• Pregnancy and breastfeeding: Generally not recommended during pregnancy as insulin is preferred; may pass into breast milk and affect nursing infants.
• Surgery and stress: May need temporary discontinuation during major surgery, severe infections, or other stressful conditions when insulin requirements change rapidly.
• Alcohol consumption: Can increase the risk of hypoglycemia and should be limited or avoided, especially on an empty stomach.

Interactions

Several medications and substances can interact with glibenclamide:

• Warfarin and anticoagulants: May enhance anticoagulant effects, requiring closer monitoring of bleeding risk.
• Beta-blockers: Can mask symptoms of hypoglycemia and prolong recovery from low blood sugar episodes.
• Fluconazole and antifungals: May increase glibenclamide levels and risk of hypoglycemia by inhibiting metabolism.
• Rifampin: Can reduce glibenclamide effectiveness by increasing its metabolism.
• ACE inhibitors: May enhance glucose-lowering effects and increase hypoglycemia risk.
• Alcohol: Significantly increases risk of severe hypoglycemia, especially when consumed without food.
• Aspirin and salicylates: High doses can enhance hypoglycemic effects.
• Gemfibrozil: Can significantly increase glibenclamide blood levels and hypoglycemia risk.

Check interactions with the GMJ Interaction Checker

Dosage

For adults with type 2 diabetes, the typical starting dose is 2.5 to 5 mg once daily, usually taken with breakfast or the first main meal. The dose may be gradually increased by 2.5 mg every 1-2 weeks based on blood glucose response, up to a maximum of 15-20 mg daily. Some patients may benefit from divided doses taken twice daily to minimize hypoglycemia risk. Dosage adjustments should always be made under medical supervision, with regular monitoring of blood glucose levels. Elderly patients typically start with lower doses due to increased sensitivity and slower drug clearance.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).